March 19 (Reuters) - CSL Ltd (CSL) :
- FERINJECT® APPROVED BY HEALTH CANADA FOR THE TREATMENT OF IRON DEFICIENCY ANEMIA IN ADULT AND PEDIATRIC PATIENTS AND IRON DEFICIENCY IN ADULT PATIENTS WITH HEART FAILURE
- CSL LTD: IN CANADA, FERINJECT IS COMMERCIALIZED THROUGH CSL BEHRING CANADA, INC., WITH AVAILABILITY EXPECTED IN SECOND HALF OF 2024
News: CSL Ferinject Approved By Health Canada For The Treatment Of Iron Deficiency Anemia In Adult...
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$278.32 |
Change
0.120(0.04%) |
Mkt cap ! $134.4B | |||
| Open | High | Low | Value | Volume |
| $277.56 | $278.32 | $275.04 | $142.4M | 513.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1738 | $278.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $278.38 | 901 | 2 |
View Market Depth
| Last trade - 16.10pm 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$278.05 |
Change
0.120 ( 0.41 %) |
||||
| Open | High | Low | Volume | ||
| $277.51 | $278.25 | $275.04 | 50767 | ||
| Last updated 15.59pm 30/05/2024 ? | |||||
| CSL (ASX) Chart |